Danny Gallant

Leveraging functional genomic approaches in genetically engineered mouse models (GEMMs), patient derived xenografts (PDXs), and cell lines to identify transcriptional and epigenetic mechanisms that promote tumor plasticity. Specifically, I am utilizing these approaches to unlock novel therapeutic strategies in small cell lung cancer (SCLC).

Mentor: Arnaud Augert